UK: AstraZeneca issues €1.5bn fixed-rate bonds in two tranches

UK-headquartered Anglo-Swedish global biopharmaceutical company, AstraZeneca, has issued €1.5bn (US$1.6bn) in fixed-rate bonds split between two equally sized tranches over four and nine years. The €750m due March 2027 notes pay a coupon of 3.625% and were priced to yield 25 basis points over mid-swaps, and the €750m due March 2032 notes pay 3.750% and…

You must be a HMI Subscriber to view this content.

Subscribe Now »